Directori de persones
Marcelino Bermudez Lopez

Marcelino Bermudez Lopez

Grau: Doctor

973 70 24 82
mbermudez(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/C-3787-2011

Publicacions

  • Borràs, Mercè; Cambray, Serafí; Crespo-Masip, Maria; Pérez-Fontán, Miguel; Bozic, Milica; Bermudez-López, Marcelino; Fernández, Elvira; Betriu, Àngels; Valdivielso, José M.

    Peritoneal Dialysis Is an Independent Factor Associated to Lower Intima Media Thickness in Dialysis Patients Free From Previous Cardiovascular Disease

    Frontiers in physiology 9 1743-1743. .

    [doi:10.3389/fphys.2018.01743]

  • Palanca, A; Castelblanco, E; Perpinan, H; Betriu, A; Soldevila, B; Valdivielso, JM; Bermudez, M; Duran, X; Fernandez, E; Puig-Domingo, M; Groop, PH; Alonso, N; Mauricio, D

    Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes

    Atherosclerosis 276 50-57. .

    [doi:10.1016/j.atherosclerosis.2018.07.018]

  • Bozic M; Betriu A; Bermudez-Lopez M; Ortiz A; Fernandez E; Valdivielso JM

    Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients

    Clinical Journal Of The American Society Of Nephrology 13 577-584. .

    [doi:10.2215/CJN.07980717]

  • Bermúdez-López M; Betriu À; Valdivielso JM; Bretones Del Pino T; Arroyo D; Fernández E

    Beyond the traditional lipid parameters in chronic kidney disease.

    Nefrologia 38 109-113. .

    [doi:10.1016/j.nefro.2017.09.008]

  • Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E

    Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound

    PLOS ONE 12 e0186665-. .

    [doi:10.1371/journal.pone.0186665]

  • Bermúdez-López M; Arroyo D; Betriu À; Masana L; Fernández E; Valdivielso JM

    New perspectives on CKD-induced dyslipidemia

    Expert Opinion On Therapeutic Targets 21 967-976. .

    [doi:10.1080/14728222.2017.1369961]

  • Bermúdez-López M; Villoria MT; Esteras M; Jarmuz A; Torres-Rosell J; Clemente-Blanco A; Aragon L

    Sgs1's roles in DNA end resection, HJ dissolution, and crossover suppression require a two-step SUMO regulation dependent on Smc5/6

    GENES & DEVELOPMENT 30 1339-1356. .

    [doi:10.1101/gad.278275.116]

  • Bermúdez-López M; Pociño-Merino I; Sánchez H; Bueno A; Guasch C; Almedawar S; Bru-Virgili S; Garí E; Wyman C; Reverter D; Colomina N; Torres-Rosell J

    ATPase-Dependent Control of the Mms21 SUMO Ligase during DNA Repair

    Plos Biology 13 e1002089-. .

    [doi:10.1371/journal.pbio.1002089]

  • Almedawar, Seba; Colomina, Neus; Bermudez-Lopez, Marcelino; Pocino-Merino, Irene; Torres-Rosell, Jordi

    A SUMO-Dependent Step during Establishment of Sister Chromatid Cohesion

    CURRENT BIOLOGY 22 1576-1581. .

    [doi:10.1016/j.cub.2012.06.046]

  • Bermudez-Lopez, Marcelino; Ceschia, Audrey; de Piccoli, Giacomo; Colomina, Neus; Pasero, Philippe; Aragon, Luis; Torres-Rosell, Jordi

    The Smc5/6 complex is required for dissolution of DNA-mediated sister chromatid linkages.

    NUCLEIC ACIDS RESEARCH 38 6502-6512. .

    [doi:10.1093/nar/gkq546]

  • Valdivielso JM; Bozic M; Galimudi RK; Bermudez-López M; Navarro-González JF; Fernández E; Betriu À; NEFRONA investigators

    Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease.

    NEPHROLOGY DIALYSIS TRANSPLANTATION -. .

    [doi:10.1093/ndt/gfy207]

  • Sánchez E; Lecube A; Betriu À; Hernández C; López-Cano C; Gutiérrez-Carrasquilla L; Kerkeni M; Yeramian A; Purroy F; Pamplona R; Farràs C; Fernández E; Barbé F; Simó R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M

    Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project.

    DIABETES METAB -. .

    [doi:10.1016/j.diabet.2018.04.002]